Dube Susan 4
4 · Somaxon Pharmaceuticals, Inc. · Filed Feb 19, 2009
Insider Transaction Report
Form 4
Dube Susan
Senior VP, Corp and Bus Dev
Transactions
- Award
Stock Option (right to purchase)
2009-02-17+40,000→ 40,000 totalExercise: $2.18Exp: 2019-02-16→ Common Stock (40,000 underlying) - Award
Common Stock
2009-02-17+18,886→ 76,386 total
Holdings
- 35,000(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]These shares are represented by restricted stock units ("RSUs"). These RSUs will vest on the six month anniversary of the completion of a financing or a strategic collaboration (or last of a series of financing or collaboration transactions) yielding aggregate proceeds of $25 million or more to the Company during the calendar year 2009, subject to the reporting person's continued service to the Company through such vesting date.
- [F2]25% of the number of shares of common stock subject to the option vest on the first anniversary of the date of grant, and 1/36 of the total remaining number of shares of common stock subject to the option vest on the first day of each month thereafter.
- [F3]Not applicable to this transaction.